Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

McMaster University

$120,000.00

A Clinical Prediction Model for the Diagnosis of Immune Thrombocytopenia

FY 2022-23

Summary
Immune thrombocytopenia (ITP) is a common bleeding disorder caused by low blood platelets. Doctors often get the diagnosis wrong because other blood conditions can look just like ITP. Without a reliable way of reaching the diagnosis, patients end up waiting longer than necessary to get the proper care, they may be prescribed the wrong treatments, and they suffer undue anxiety and stress. Our research group developed the Predict-ITP Tool to help doctors identify which patients have ITP in the clinic. The Predict-ITP Tool was developed using information from a group of more than 800 patients and classifies patients as having or not having the ITP diagnosis, based on the following patient characteristics: 1) fluctuations in platelet count levels over time; 2) the lowest recorded platelet count level in the recent past; 3) the highest mean platelet volume (a marker of platelet size); and 4) a major bleed at any time in the past. Our preliminary study showed that the tool could successfully identify patients with ITP. The objective of this project is to validate the Predict-ITP Tool using information from hematology patients from across Canada. We will collect data from 960 patients (15% with and 85% without ITP) from 11 hematology clinics to see how well the Predict-ITP Tool would have been able to predict which patients had ITP and which ones did not at the time of the initial hematology consultation. We will compare the results obtained using the new tool with the ultimate diagnosis determined by the hematologist over time. An independent committee of experts will adjudicate the diagnosis of ITP when it is uncertain. Our team includes ITP researchers, hematologists, statisticians and a patient representative. The Predict -ITP Tool will address an important gap in patient care by reducing the lag time to reach a proper diagnosis, avoiding the use of unnecessary treatments, reducing health care costs and improving patients' well-being.
Program
Project Grant
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
480268
Name
Arnold Donald M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Clinical Investigation - C: Digestive, Endocrine and Excretory Systems
Projecttitle
A Clinical Prediction Model for the Diagnosis of Immune Thrombocytopenia
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Clinical Prediction Model; Immune Thrombocytopenia (Itp); Platelets
Abstract
Immune thrombocytopenia (ITP) is a common bleeding disorder caused by low blood platelets. Doctors often get the diagnosis wrong because other blood conditions can look just like ITP. Without a reliable way of reaching the diagnosis, patients end up waiting longer than necessary to get the proper care, they may be prescribed the wrong treatments, and they suffer undue anxiety and stress. Our research group developed the Predict-ITP Tool to help doctors identify which patients have ITP in the clinic. The Predict-ITP Tool was developed using information from a group of more than 800 patients and classifies patients as having or not having the ITP diagnosis, based on the following patient characteristics: 1) fluctuations in platelet count levels over time; 2) the lowest recorded platelet count level in the recent past; 3) the highest mean platelet volume (a marker of platelet size); and 4) a major bleed at any time in the past. Our preliminary study showed that the tool could successfully identify patients with ITP. The objective of this project is to validate the Predict-ITP Tool using information from hematology patients from across Canada. We will collect data from 960 patients (15% with and 85% without ITP) from 11 hematology clinics to see how well the Predict-ITP Tool would have been able to predict which patients had ITP and which ones did not at the time of the initial hematology consultation. We will compare the results obtained using the new tool with the ultimate diagnosis determined by the hematologist over time. An independent committee of experts will adjudicate the diagnosis of ITP when it is uncertain. Our team includes ITP researchers, hematologists, statisticians and a patient representative. The Predict -ITP Tool will address an important gap in patient care by reducing the lag time to reach a proper diagnosis, avoiding the use of unnecessary treatments, reducing health care costs and improving patients' well-being.
Competitiondate
202303
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Arnold, Donald M
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~
McMaster University - $120,000 Grant (2022-23) | Canada Spends